GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $208,000 | -15.8% | 5,825 | -13.4% | 0.00% | -25.0% |
| Q4 2020 | $247,000 | -2.4% | 6,725 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $253,000 | -7.7% | 6,725 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $274,000 | +5.0% | 6,725 | -2.2% | 0.01% | -25.0% |
| Q1 2020 | $261,000 | -19.2% | 6,876 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $323,000 | +10.2% | 6,876 | 0.0% | 0.01% | +12.5% |
| Q3 2019 | $293,000 | +6.5% | 6,876 | 0.0% | 0.01% | -11.1% |
| Q2 2019 | $275,000 | -4.2% | 6,876 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $287,000 | +9.1% | 6,876 | 0.0% | 0.01% | -10.0% |
| Q4 2018 | $263,000 | -4.7% | 6,876 | 0.0% | 0.01% | +11.1% |
| Q3 2018 | $276,000 | -0.4% | 6,876 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $277,000 | +3.0% | 6,876 | 0.0% | 0.01% | -9.1% |
| Q1 2018 | $269,000 | -1.1% | 6,876 | -10.4% | 0.01% | 0.0% |
| Q4 2017 | $272,000 | -28.6% | 7,676 | -18.1% | 0.01% | -35.3% |
| Q3 2017 | $381,000 | -5.7% | 9,376 | 0.0% | 0.02% | -5.6% |
| Q2 2017 | $404,000 | +2.3% | 9,376 | 0.0% | 0.02% | 0.0% |
| Q1 2017 | $395,000 | -13.2% | 9,376 | -20.7% | 0.02% | -21.7% |
| Q4 2016 | $455,000 | +19.4% | 11,826 | +34.0% | 0.02% | +15.0% |
| Q3 2016 | $381,000 | -0.5% | 8,826 | 0.0% | 0.02% | -4.8% |
| Q2 2016 | $383,000 | +7.0% | 8,826 | 0.0% | 0.02% | -4.5% |
| Q1 2016 | $358,000 | -3.0% | 8,826 | -3.7% | 0.02% | -4.3% |
| Q4 2015 | $369,000 | +4.8% | 9,167 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $352,000 | -7.9% | 9,167 | 0.0% | 0.02% | -8.0% |
| Q2 2015 | $382,000 | -9.7% | 9,167 | 0.0% | 0.02% | -10.7% |
| Q1 2015 | $423,000 | -22.4% | 9,167 | -28.1% | 0.03% | -22.2% |
| Q4 2014 | $545,000 | -9.8% | 12,756 | -3.0% | 0.04% | -14.3% |
| Q3 2014 | $604,000 | -12.1% | 13,146 | +2.3% | 0.04% | -14.3% |
| Q2 2014 | $687,000 | +10.1% | 12,846 | +10.0% | 0.05% | -2.0% |
| Q1 2014 | $624,000 | +13.9% | 11,679 | +13.8% | 0.05% | -9.1% |
| Q4 2013 | $548,000 | -12.7% | 10,259 | -18.0% | 0.06% | -24.7% |
| Q3 2013 | $628,000 | +0.5% | 12,509 | 0.0% | 0.07% | -13.1% |
| Q2 2013 | $625,000 | – | 12,509 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |